相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey
Martina Bocchetta et al.
ALZHEIMERS & DEMENTIA (2015)
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
Stephanie J. B. Vos et al.
BRAIN (2015)
Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages
Carlos Cabral et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2015)
Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
Anna Caroli et al.
NEUROLOGY (2015)
Volume of interest-based [F-18] fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
M. Pagani et al.
NEUROIMAGE-CLINICAL (2015)
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia
Chiara Cerami et al.
NEUROIMAGE-CLINICAL (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia
Paula T. Trzepacz et al.
NEUROBIOLOGY OF AGING (2014)
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Daniela Perani et al.
NEUROIMAGE-CLINICAL (2014)
Impact of molecular imaging on the diagnostic process in a memory clinic
Rik Ossenkoppele et al.
ALZHEIMERS & DEMENTIA (2013)
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series
Annapaola Prestia et al.
ALZHEIMERS & DEMENTIA (2013)
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia
Javier Arbizu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
A. Bruck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD
Samantha Galluzzi et al.
JOURNAL OF NEUROLOGY (2013)
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Annapaola Prestia et al.
NEUROLOGY (2013)
Imaging markers for Alzheimer disease Which vs how
Giovanni B. Frisoni et al.
NEUROLOGY (2013)
Diagnosed Mild Cognitive Impairment Due to Alzheimer's Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction
Shizuo Hatashita et al.
PLOS ONE (2013)
Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers
Jennifer L. Shaffer et al.
RADIOLOGY (2013)
Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment
Jonathan Young et al.
NEUROIMAGE-CLINICAL (2013)
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
Rik Ossenkoppele et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Summary Metrics to Assess Alzheimer Disease Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison
Anna Caroli et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses
Paule-Joanne Toussaint et al.
NEUROIMAGE (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment
Karl Herholz et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years
Jose V. Pardo et al.
ALZHEIMERS & DEMENTIA (2010)
MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings
M. Pagani et al.
CURRENT ALZHEIMER RESEARCH (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree?
Fiona E. Matthews et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment
Andreas Fellgiebel et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2007)
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease
D Anchisi et al.
ARCHIVES OF NEUROLOGY (2005)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Mild cognitive impairment -: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
G Chételat et al.
NEUROLOGY (2003)
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
K Herholz et al.
NEUROIMAGE (2002)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Classification criteria for mild cognitive impairment - A population-based validation study
K Ritchie et al.
NEUROLOGY (2001)
Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling
PJ Magistretti
BRAIN RESEARCH (2000)
分享论文
